title: Treatment with intravenous immunoglobulin is not a panacea but should be limited to those who can benefit.
authors.forename: Peter
authors.initials: P
authors.lastname: Ganly
authors.forename: Ruth
authors.initials: R
authors.lastname: Spearing
mesh_terms: D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000191:economics / Q000627:therapeutic use*; D009520:New Zealand; D017410:Practice Guidelines as Topic; D011306:Prescription Fees; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*
chemical_list: D016756:Immunoglobulins, Intravenous